For these reasons and because the reduction of various butyrate-producing bacteria is probably involved in the reduction of BDNF expression at the hippocampal level [63], it seems useful to suggest future research to further evaluate the possibility of implementing BD patients’ treatment response through prebiotics. The gene discussed is BDNF; the disease is Behcet disease.